or anti-DNA, C3, or C4 levels may indicate possible SLE flare and/or preeclampsia despite absence of clinical symptoms. Frequency of laboratory monitoring and rheumatology followup may vary with an individual patient's clinical status and medications. Antiphospholipid antibody is a major risk factor for pregnancy loss and other adverse pregnancy outcomes, especially in SLE patients Antiphospholipid antibody Antiphospholipid antibody-positive patients without thrombosis or obstetric